Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Sort descending Drug Company PI Date Risk List Available?
Linezolid Macleods Pharmaceuticals Ltd June 2019
Linezolid (Zyvox) Pfizer November 2021
Lopinavir/Ritonavir (Kaletra) AbbVie April 2023 YES
Moxifloxacin (Avelox) Bayer May 2019
Moxifloxacin (Lonxave) Macleods Pharmaceuticals May 2020
Peginterferon alfa 2b (Pegintron) Merck August 2019
Pitavastatin (Livalo) Kowa November 2022
Pyrazinamide Macleods Pharmaceuticals Limited August 2018
Raltegravir (Isentress) Merck May 2022 YES
Ribavirin Aurobindo Pharma Limited April 2022
Rifabutin Greenstone LLC February 2023
Rifampicin Macleods Pharmaceuticals Ltd November 2018
Rifampicin Macleods Pharmaceuticals Limited December 2018
Rifampicin/Isoniazid Lupin Ltd February 2018
Rifampicin/Isoniazid Macleods Pharmaceuticals Ltd September 2017
Rifampicin/Isoniazid Macleods Pharmaceuticals Ltd November 2018
Rifampicin/Isoniazid (Isonarif) VersaPharm Incorporated March 2012
Rifampicin/Isoniazid/Pyrazinamide/Ethambutol Hydrochloride Macleods Pharmaceuticals Ltd October 2018
Rifampin/Isoniazid/Pyrazinamide/Ethambutol (Rifafour e-276) Sanofi-Aventis April 2013
Rifapentine (Priftin) Sanofi-Aventis July 2021 YES